FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 1 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is - and the average weighting 5.7%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,508 | $3,783,591 | 5.70% |
External links
This page lists FREELINE THERAPEUTICS HLDGS's shareholders in Q2 2023. To view FREELINE THERAPEUTICS HLDGS's shareholder history, click here.